Genetic Predisposition: Clinical Trials

2 trials for Genetic Predisposition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow Genetic Predisposition: new trials by email Literature Review of Genetic Predisposition trials Research Report on Genetic Predisposition

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
oral semaglutide, Mixed Meal Tolerance Test (MMTT) - Genetic Predisposition, Metabolic Diseases
Phase 4RecruitingMassachusetts General Hospital1252024-03-122026-07-08
Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING)
Varenicline Tartrate or bupropion - Smoking Cessation, Genetic Predisposition
Phase 4CompletedUniversity of Sao Paulo General Hospital3612016-11-012022-12-21

Narrower conditions

Genetic Predisposition to Disease (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Metabolic Diseases (1)  ·  Smoking Cessation (1)

Broader conditions

Disease Attributes (2)  ·  Disease Susceptibility (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Behavior (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Health Behavior (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Bupropion (1)  ·  Varenicline (1)  ·  semaglutide (1)

Sponsors

Massachusetts General Hospital (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (1)  ·  United States (1)

Top investigators

Jaqueline R Scholz, MD.Phd (1)  ·  Josephine Li, MD (1)

Results publications

PMID 38628555, PMID 38756738

NIH funding

K23DK131345 (1)